Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
This study has been terminated.
Study NCT00576602   Information provided by Hoffmann-La Roche
First Received: December 18, 2007   Last Updated: September 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Hematologic Diseases
Kidney Failure
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Supportive treatment
Additional drug interventions recognized in this trial
Hematinics
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Hoffmann-La Roche


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services